期刊
DIAGNOSTICS
卷 10, 期 8, 页码 -出版社
MDPI
DOI: 10.3390/diagnostics10080568
关键词
ovarian cancer cytoreduction; neoadjuvant chemotherapy; preoperative predictors of optimal tumor cytoreduction
Ovarian cancer is the deadliest gynecologic cancer, in part due to late presentation. Many women have vague early symptoms and present with disseminated disease. Cytoreductive surgery can be extensive, involving multiple organ systems. Novel therapies and recent clinical trials have provided evidence that, compared to primary cytoreduction, neoadjuvant chemotherapy has equivalent survival outcomes with less morbidity. There is increasing need for validated tools and mechanisms for clinicians to determine the optimal management of ovarian cancer patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据